Abstracts (HTML) List of Authors

Kahle, Jörg

Nonneutralizing Factor VIII Antibodies as a Marker for Inhibitor Development in a Longitudinal Cohort of Hemophilia A Patients

Kahre, Elisabeth

Evaluation of Individualized Physiotherapy in Pediatric Patients with Severe Bleeding Disorders

Kaiser, Katharina

Einfluss des Von-Willebrand-Faktors auf die porcine Angiogenese über das TIE-System

Karl, Lackner

Influence of Thrombotic Thrombocytopenic Purpura on Depressivity, Cognitive Conduction, Quality of Life, and Resilience of Patients

Kaya, Esra

Characterization of FVIII Pharmacokinetics in Hemophilia A Patients with or without Nonneutralizing FVIII Antibodies

Keipert, Christine

Das neue DHR

Kemkes-Matthes, Bettina

Familial Multiple Coagulation Factor Deficiencies: Follow-up Analyses

Kerstan, A.

FXIII Protein Inhibitor against the FXIII-A Subunit in an 8-Year-Old Boy with Inherited Severe Factor XIII Deficiency Complicated by Multiple Intracerebral Cavernomas

Kersten, Alexa

Hämophilietherapie im Wandel: Auswirkungen auf das Gerinnungslabor

Kiesewetter, Holger

Ersteinstellung und Umstellung auf Emicizumab

Klamroth, Robert

Recombinant Porcine Factor VIII in Patients with Acquired Hemophilia A: Single-Center Experience and Dosing Strategy

Klein, C.

FXIII Protein Inhibitor against the FXIII-A Subunit in an 8-Year-Old Boy with Inherited Severe Factor XIII Deficiency Complicated by Multiple Intracerebral Cavernomas

Klein, Claudia

Provision of Psychological Services in Hemophilia Treatment Postulated under the Guidelines of the WFH and the GTH—But Also in Demand? Experiences from the Hemophilia Center Bonn
Hämophilietherapie im Wandel: Auswirkungen auf das Gerinnungslabor
Successful Embryo Transfer and Pregnancy with Donated Egg in a Female with Severe FXIII Deficiency and Climacterium Praecox

Klingebiel, Thomas

Signature of the Antibody Response to FVIII
Nonneutralizing Factor VIII Antibodies as a Marker for Inhibitor Development in a Longitudinal Cohort of Hemophilia A Patients

Knöbl, Paul N.

The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: Key findings at Enrolment until 2017

Knöfler, Ralf

Evaluation of Individualized Physiotherapy in Pediatric Patients with Severe Bleeding Disorders

Kokame, Koichi

The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: Key findings at Enrolment until 2017

König, Gesa

Degradation of VWD Type 2B Variants by ADAMTS-13 in Simulated Circulation
Functional and Structural Properties of the 2nd Gain-of-Function Variant in the C4 Domain of von Willebrand Factor

Königs, C.

Responsiveness of PBMCs Isolated from Healthy Individuals toward rFVIII and rFVIIIFc

Königs, Christoph

Characterization of FVIII Pharmacokinetics in Hemophilia A Patients with or without Nonneutralizing FVIII Antibodies
Signature of the Antibody Response to FVIII
Nonneutralizing Factor VIII Antibodies as a Marker for Inhibitor Development in a Longitudinal Cohort of Hemophilia A Patients

Kopf, L.

Randomisiert-kontrollierte Cross-Over Studie zur Effektivität der manuellen Lymphdrainage bei Patienten mit schwerer Hämophilie

Kragh, T.

Ongoing Effect of Therapeutic rVWF in Patients with Severe VWD

Kramer, Sonja

Emicizumab – Erfahrungen zur Anwendung bei Kindern mit Hämophilie und Hemmkörpern

Krettler, Christoph

Alpha-2 Macroglobulin: A Novel Putative Interacting Partner of FXIII/FXIIIB Subunit?

Krüger, Steffen

AIM-Active-Studie – Hintergrund – Ziel – Design

Kubicek-Hofmann, Cornelia

Recombinant Porcine Factor VIII in Patients with Acquired Hemophilia A: Single-Center Experience and Dosing Strategy

Kurme, Anatol

Fit for Life Fitness-App – sicheres und effektives Training in Fitnesseinrichtungen

Kurnik, Karin

Emicizumab – Erfahrungen zur Anwendung bei Kindern mit Hämophilie und Hemmkörpern